Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Tapentadol Tablets For Moderate To Scute Pain In Over 18s Now Available For Use In The United States
German pain expert company GrÃønenthal GmbH announces that the new centrally acting analgesic tapentadol is now available in the United States. The drug is indicated for the relief of moderate to severe acute pain in patients 18 years of age and older. Approval was given by the US Food and Drug Administration (FDA) in November 2008 for tapentadol (NUCYNTATM) tablets. With the cooperation of GrÃønenthal and its marketing partner Ortho-McNeil-Janssen Pharmaceuticals, Inc., the medication can now be prescribed by physicians and other appropriate health care professionals in the United States.
generic viagra online
Management Change At Actelion - Isaac Kobrin To Take Newly Created Position Of Chief Medical Officer
Actelion Ltd (SIX: ATLN) announced the creation of the position of Chief Medical Officer (CMO). This change was initiated to fulfill the needs of a fast growing organization, which is developing products rapidly and managing a growing portfolio. Effective 1 July 2009, the current Head of Clinical Development, Isaac Kobrin will move into this position. He will continue to be a member of Actelion"s Executive Committee (AEC).
News of the day
For HCV-Positive Liver Transplant Recipients, Some Donor Factors Affect Outcomes
Two new studies address donor factors that could affect outcomes for liver transplant recipients, particularly those with chronic hepatitis C (HCV). One found that donor steatosis, or fat in the liver, does not affect liver disease progression or three-year survival in recipients with or without HCV. However, transplants from people higher on the Donor Risk Index did adversely affect the outcomes of HCV-positive recipients more than recipients without HCV.
Medical Devices

New York Times Examines Program To Help Orphans Survive 'Fragile Days Of Infancy'

The New York Times examines a program being offered at an orphanage in Tanzania that provides emotional and physical support for newborns and young children who are at a high risk of death after losing their mothers in infancy. "Africa is full of at least 50 million orphans, the legacy of AIDS and other diseases, war and high rates of death in pregnancy and childbirth," the newspaper writes. "With the numbers increasing every day, Africans are struggling to care for them, often in ways that differ strikingly from the traditional concept of an orphanage in the developed world." The article details one such program being offered at the Berega Orphanage, where newborns are temporarily housed along with a teenage girl from their extended family through "the fragile days of infancy." Once the infants are "big enough to digest cow"s milk and eat regular food," they are returned to their villages," the newspaper writes. "Programs like the one in Berega are "the way to go" in Africa, said Dr. Peter Ngatia, the director of capacity building for Amref, the African Medical and Research Foundation, a nonprofit group based in Nairobi, Kenya," the newspaper writes. "He said similar programs for AIDS orphans had worked well in Uganda, looking after the children until age 5 and then sending them back to their families or volunteers in their communities." In addition to benefiting the babies, the program helps the teenage girls caring for them. The New York Times writes, "Many arrive illiterate and leave knowing how to read. [The program director] also teaches them the basics about health, and they learn sewing and batik, and share the cooking in an outdoor kitchen" (Grady, New York Times, 6/25). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009